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targets for peer review as a routine quality assurance tool. It is hoped that this work will be a
catalyst for further investigation, development, and study of the efficacy of peer review techniques
and how these efforts can help improve the safety and quality of our treatments.
© 2013 American Society for Radiation Oncology. Published by Elsevier Inc. Open access under 
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The full report is part of a series of white papers
addressing patient safety commissioned by the American
Society for Radiation Oncology (ASTRO) Board of Di-
rectors as part of ASTRO's Target Safely Campaign. The
full length document was approved by the ASTRO Boardof Directors on September 11, 2012 and has been endorsed
by the American Association of Physicists in Medicine,
American Association of Medical Dosimetrists, and
the American Society of Radiologic Technologists. The
document has also been reviewed and accepted by the
American College of Radiology's Commission on Radi-
ation Oncology. These organizations have a long history
of supporting efforts toward improving patient safety in
the United States.
This report is related to other published reports of the
ASTRO white paper series on patient safety, including
those on intensity modulated radiation therapy (IMRT)
and stereotactic body radiation therapy (SBRT), and those
still in preparation. There are sections of this report that
defer to guidance in these reports.
1.0 Introduction
Peer review, also known as audit and feedback, is a
valuable tool central to quality management or quality
assurance (QA) programs.1
While peer review has been accepted as an important
aspect of quality efforts (especially of physicians' deci-
sions) in radiation oncology for many years, there is cur-
rently little specific guidance and limited published
literature. The goals of this report are to:
a. provide a summary of current recommendations;
b. review potential peer review targets and to discuss
prioritization and rationale; and
c. propose improvements in processes or technology that
may facilitate or improve peer review, and acknowl-
edge associated challenges.
1.1 Current peer review recommendations within
radiation oncology
Available only at www.practicalradonc.org.
1.2 Prior work on peer review in radiation
oncology
Brundage et al2 assessed the real-time pretreatment
review of 3052 treatment plans over 8 years. They found
that such pre-radiation therapy peer review was feasible,
and that plan modifications were recommended in
Figure 1 A quality management program must address
medical and qualitative steps (left side) as well as technical and
quantifiable process-related steps (right side) to implement the
medical directive. The left side is the focus of this report.
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by Boxer et al 3 noted peer review-recommended
changes in 8/208 patients (4%). A posttreatment peer
audit of ~80 cases also noted that ≈5% of patients had
apparent controversial/concerning medical decisions
made regarding things such as treatment intent, dose,
and fractionation.4
These latter 2 studies used peer review audit tools
created by the Royal Australian and New Zealand College
of Radiologists3 and The Cancer Institute in Singapore.4
These peer review audit tools have evolved over time in
response, in part to systematic assessments of their
reproducibility.4 Such tools have the potential to improve
practice quality, to alter patient management,4-6 and to
provide an effective means to document changes in patient
management.7 The experiences of these groups, and
components of their existing audit tools, may prove useful
in future initiatives.
The chief residents of 57/71 North American
academic radiation oncology facilities responded to an
anonymous survey addressing “peer review chart
rounds.”8 Their key findings include the following: (1)
providing protected time and monitoring attendance was
associated with better participation by senior faculty; (2)
review of routine external beam cases was more
common (where 80% of institutions reported peer
review of all cases) than for radiosurgery or brachy-
therapy (where 58%, and 40%-47% of centers reported
review of cases, respectively); (3) 60% reported that the
duration of chart rounds was b2 hours per week (range,
1–6); (4) the median time spent per patient was
2.7 minutes (range, 0.6-12 minutes); and (5) minor
and major changes were relatively uncommon as a result
of chart rounds; 14% of respondents estimated that
minor changes (eg, small multileaf collimator change or
request to repeat a port film) were requested in ≥20% of
cases, and 61% of respondents estimated that minor
changes were requested in b10% of cases; 11% of
respondents estimated that major changes (eg, to the
dose prescription or treatment plan) occurred in ≥10%
of cases, and 75% of respondents estimated that major
changes occurred in b10% of cases.8
1.3 Programmatic peer review and maintenance
of certification programs
Available online only at www.practicalradonc.org.
1.4 Peer review: QA for professional
qualitative decisions
1.4.1 Peer review versus process control
This paper concentrates on patient-specific peer
review in radiation oncology; ie, peer review for items
linked to a specific patient (eg, dose distribution), ratherthan global processes that effect patients more broadly
(eg, machine calibration). Patient care processes can be
broadly divided into a series of medical (often
qualitative) decisions that often do not have clear right
or wrong answers (eg, a physician's prescription of
dose-volume) and a series of more quantitative technical
tasks or programs to implement the prescribed treatment
(typically executed by teams of therapists, dosimetrists,
and physicists) (Fig 1). This report concentrates on
ways that peer review can be used to help improve the
safety and quality related to professional decisions
made by members of the radiation oncology team (left
side of Fig 1).2.0 The traditional approach to case-oriented
peer review in radiation oncology
2.1 Chart rounds
Peer review is widely practiced, largely through “chart
rounds.” During these sessions, members of the treatment
team review each case (eg, doses, fields, treatment plans,
patient setup, etc).8-10 A recent survey suggested that such
routine peer review occurs in essentially all North American
centers with accredited residency training programs.8
2.2 Prospective pretreatment tumor boards
Tumor boards, with multiple physicians and members
of the healthcare team from diverse disciplines, are a
second common form of peer review. The group renders
opinions and advice for individual patients (eg, whether or
not to use RT). Such a multidisciplinary discussion is often
crucial, especially in complex cases; posttherapy discus-
sions are less useful.11
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3.1 General considerations
Available online only at www.practicalradonc.org.
3.2 Categorizing targets for peer review
Candidate decisions or actions that can be targeted
for peer review are summarized and divided into 6
categories corresponding to the simplified radiation
therapy process (Table 1, available online only at
www.practicalradonc.org). For each task, Table 1 de-
scribes the goal of peer review, the person who typically
performs the peer review, the ideal timing, and where
applicable, features that may facilitate the peer review. A
refined prioritization of targets is provided in the section
“Prioritizing the possible targets for peer review.”
3.3 Preplanning, physician-focused tasks
The first series of process steps are components of
medical decision making that come before the treatment
planning process. For some of these items, there are ob-
jective treatment guidelines that might be useful in
streamlining/automating peer review.
3.4 Treatment planning—dosimetry/
physics-focused tasks
The latter table entries largely focus on treatment
planning and treatment delivery. Physicians, dosimetrists,
therapists, and physicists all have critical roles in these
tasks and in their peer review. The diversity of individuals
involved reflects the large number of hand-offs and “back
and forth/iterations” that occur during the planning/
delivery process. The very nature of these processes
demands a rigorous review and QA system.
The seemingly infinite number of possible treatment
plans, and the large amount of time needed to generate
and QA a plan, make peer review of treatment planning
challenging. Often the planner and physician's experi-
ence dictates when the “best” possible plan has been
generated. This is a critical step, where peer review
might be particularly helpful. Furthermore, consideration
should be given to nonmedical issues; eg, a complicated
treatment approach may not be appropriate if the patient
is uncooperative.
3.5 Treatment delivery—therapist-focused tasks
Therapists are at the “end of the line" and are often
expected to perform a broad review of all prior activities;
eg, “Is this the correct patient and correct site?” Many of
these have clear right or wrong answers and are in reality“quality/process control” issues (ie, not technically “peer
review”). However, almost all treatment delivery errors
manifest themselves at the treatment machine. Given this
fact, it is clear that in order to maximize safety and
quality, multiple therapists are needed at the treatment
machine to check on each other, verify all the necessary
information, and try to prevent upstream errors from
getting to the treatment, while also using peer review on
qualitative issues such as setup accuracy, immobilization,
and image review.
Even with multiple therapists per machine, modern
radiation therapy expects the radiation therapists to per-
form the following numerous physical tasks in the treat-
ment room (eg, patient setup); at the treatment machine
console (eg, retrieving data from medical records, image
review/manipulation); and elsewhere (eg, retrieving pa-
tients from the clinic lobby). Having tasks performed in
multiple locations promotes a “divide and conquer”
approach that may undermine therapist peer review.
However, given the many varied tasks and speed with
which they are performed, the use of a second person to
review the actions, measurements, data entry, and machine
control aspects of the therapists’ job is a critical part of a
good QA program. The second set of eyes is a crucial
check of all the technical steps performed by the therapists
during each treatment fraction. The use of timeouts
(similar to a presurgery checklist in an operating room)
to verify the physician's prescription, the prescribed dose
programmed into the machine, and the patient's identity
help the therapist team review these most crucial aspects
of a treatment.
3.6 Prioritizing the possible targets for
peer review
Table 1 (available online only at www.practicalradonc.
org). includes a lengthy list of possible peer review targets,
and addressing each item is not practical. Thus, prioriti-
zation is needed. Candidate “high priority” targets should
be those with a high potential risk to the patient, and a low
probability that an “error” will be detected downstream
(Figure 3, available online only at www.practicalradonc.
org). There are some data to help guide this prioritization.
In the studies from Boxer et al3 and Brundage et al,2 target
volume coverage was the item most often changed during
peer review. In the Brundage et al study, 8% of plans were
identified as requiring modification. The most common
reasons for modification related to planning target
volumes (31%), protection of critical structures (15%),
selection of treatment volumes (eg, nodal volumes
included or excluded, 11%), selection of dose (11%),
and dose distribution (6%). These domains correspond to
current patterns of peer review in Ontario.2
A study from Johns Hopkins used failure modes and
effects analysis (FMEA) to identify priority targets.10 The
tasks with the highest risk probability included wrong
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the record and verify system, incorrect contours used, and
wrong computed tomographic simulation data entered for
the patient.10 However, this approach is not ideal, as
many of the events that occur in the clinic are not
predicted by the FMEA (Ford, personal communication,
2011). Additional work is certainly needed to refine this
prioritization. The recent survey of North American
teaching centers noted that the issues most commonly
modified by peer review related to normal tissue expo-
sure, the prescribed dose/fractionation schedule, target
coverage, and treatment technique.8
A suggested prioritization of targets for peer review,
associated justifications, and applicable clinical situations
are listed in Table 2. Specific recommendations for these
targets are given below.
(1) The physician's decision to treat is considered as a
level 2 priority for peer review as this is often aided
by clinical practice guidelines. Retreatment settings
are often particularly challenging (especially when
normal tissue constraints in the target volume
are compromised) and peer review may be partic-
ularly useful.
(2) General treatment approach decisions (eg, treat-
ment goal [curative, adjuvant, or palliative]; modal-
ity [eg, brachytherapy versus various external beam
approaches]; nonconformal or conformal, image
guidance, and motion management approach) are
often made by the physician in consultation with
dosimetrists, physicists, and therapists, and thus
peer review of these issues should ideally be multi-
disciplinary. This is considered as level 3 as these
decisions are often aided by clinical practice guide-
lines and recommendations.
(3) Image segmentation/contouring. Delineation of the
target volumes is the physician's responsibility.
Normal tissue segmentation is typically done pri-
marily by dosimetrists, physicists, or other spe-
cially trained staff. Structure delineation is often
guided by multimodality image registration that is
typically performed by dosimetrists, physicists, or
other specially trained staff. Peer review of
segmentation/fusion (as well as the images chosen
for segmentation) should ideally be done prior to
treatment planning as much of the subsequent work
is dependent on the details of the segmentation/
fusion. This is one of the most important medical
decisions that likely would benefit from peer
review. Because there are significant, often marked
interpatient variations in the target volumes, and
because mistargeting can lead to poor clinical
outcomes, this is considered as one of the most
critical areas for peer review (ie, level 1),
especially in patients being treated with curative
intent and with highly conformal approaches (as isoften the case for image guided radiation therapy
[IGRT] and SBRT). Segmentation of the normal
tissues is considered level 3 as this is often guided
by atlases.
(4) Planning directive. The planning goals (eg, desired
dose-volume parameters and limits) are often based
on existing guidelines. Nevertheless, these decisions
are often somewhat qualitative, and are thus con-
sidered level 2. This peer review should ideally be
performed prior to initiation of treatment planning
(particularly if the planning process is anticipated to
be time consuming and highly dependent on the
planning goals), or prior to the initiation of therapy (if
the planning process is less time consuming and less
dependent on the planning goals). This might be
most important in the settings where there are not
clear clinical guidelines (eg, the retreatment setting)
or when normal tissue and target constraints are in
conflict. Similarly, changes in the planning goals or
image segmentation made during the course of
therapy (ie, adaptive therapy) may also benefit
from peer review.
(5) Technical plan quality. Evaluation of the plan's
quality, relative to the planning goals, is usually
made by the treating physician, in consultation with
the dosimetrist/physicist who is typically familiar
with the technical tradeoffs and compromises made
during planning. Peer review for planning evaluates
2 types of decisions from the planning process: the
physician-driven clinical tradeoffs (ideally addressed
through physician peer review), and the more
technical aspects of the plan's ability to achieve the
desired dose-volume results with reasonable com-
plexity and deliverable fields (ideally addressed
through dosimetrist/physicist peer review).
(6) Setup accuracy and consistency. A radiation thera-
pist is responsible for daily setup accuracy, and thus a
second radiation therapist should ideally provide
daily review; ie, 1 therapist setting the patient up with
a second verifying, or the 2 therapists working
together and checking each other. In more challeng-
ing cases (eg, SBRT), a physicist and/or physician
should also provide peer review of the therapist's
activities. Similar peer review should ideally be
performed for other therapist activities such as
review of daily pretreatment setup images, or review
of respiratory gating parameters. This is identified
as a critical target for peer review, especially in
curative cases, and in IMRT and SBRT cases where
port films do not provide an independent assessment
of the treated volume.
3.7 Operational implementation/prioritization
See full text version available only at www.
practicalradonc.org.
Table 2 Prioritization of targets for peer review
Item for
peer review
Prioritization Rationale for priority level Timing of peer review
and associated comments
Example clinical
situations where peer
review is anticipated
to be particularly useful
1) Decision to include
radiation as part of
treatment
Level 2 Guidelines often exist, but these
decisions are often individualized
Pretherapy preferred Unusual/nonguideline
cases
2) General radiation
treatment approach
Level 3 There are many guidelines and
best practice statements that
address this issue. If standard
dose/volume constraints are
respected, patient risks are low
regardless of the specific RT
approach taken.
Preradiation preferred. Altering
some aspect of the treatment
approach once RT has been
initiated can be cumbersome
(eg, image guidance approach),
while other aspects are more
easily changed during RT.
The safest environment is one
where mid-treatment changes
are minimized.
Retreatment cases
3) Target definition⁎ Level 1 Every patient's tumor is
different and visualization on
different types of images can
vary. Each image fusion is
unique.
Pretreatment peer review of how
targets are defined (eg, which
images and which "pixels") is
critical as mistargeting can lead
to poor clinical outcomes.
Preplanning review is ideal but
is not critical for every case.
Tight margins; eg, SBRT
4) Normal tissue image
segmentation
Level 3 There are atlases for normal
tissues.
Review of normal tissues can be
done during RT since the risks are
less (especially for fractionated
regiments). Normal tissue pre-RT
peer review needed for single and
hypofractionation cases.
Tight margins; eg, SBRT
5) Planning directive
(dose/volume goals/
constraints for
targets and normal
tissues)
Level 2 Patient risks are low if standard
dose/volume limits are respected.
Guidelines and best practice
recommendations often exist, but
these decisions are often
individualized.
Preplanning or pretreatment
6) Technical plan
quality
Level 2 Normal tissue dose/volume
guidance documents are
generally available, but the
compromises between normal
tissue vs target doses are often
patient specific.
For conventional fractionation,
this may be acceptable to perform
during RT, as there is usually an
opportunity to alter the plan. The
safest environment is one where
mid-treatment changes are
minimized.
IMRT, SBRT
7) Treatment delivery
(eg, patient setup)
First day is
Level 1,
especially for
curative
cases. Other
days are
Level 2.
The first day's setup is critical
to avoid systematic errors and
their propagation.
Therapist peer review of setup
must be done pre-RT for the first
fraction, and ideally for all
subsequent fractions. Portal or
localization image peer review
must be done before the second
treatment. Physicist and physician
involved with pretreatment QA
for complex cases (eg, SBRT).
IMRT (since portal or
localization imaging
often does not provide
independent assessment
of target volume location)
Level 1 indicates highest priority for peer review (where there are marked interpatient variations), Level 2 next highest (where there are often
guidelines/atlases to aid in decision), and Level 3 the next (other targets for peer review).
RT, radiation therapy; IMRT, intensity modulated radiation therapy; SBRT, stereotactic body radiation therapy.
⁎ Target definition includes the decision regarding the need for multimodality imaging, the fusion of the images, and the target definitions on the images.
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Implementing effective peer review can be challenging.
There are often competing demands and rigid computer-
workflow systems that do not readily facilitate or support
peer review. Table 3 (available online only at www.
practicalradonc.org) offers a list of potential barriers to
effective peer review, possible interventions, and recom-
mendations that may help improve the effectiveness of
peer review. The section below offers a more detailed
description of examples of suggested improvements and
tools that might help make peer review more effective and
efficient. The themes raised are potentially more important
than the precise methods of implementation.4.1 Example process improvements
The full details of this section are available in the full
text version (available online only at www.practicalradonc.
org). The outline of this section is as follows:
a. Management
b. Allotting necessary resources and time
c. Facilities
d. Creating a collaborative atmosphere
e. Knowing each other's names
f. Minimizing distractions and maintaining clearly-
defined roles and expectations
4.2 Example technological improvements
This section recommends a number of changes in
software and other technologies that the vendors should
consider since they may help improve the efficiency,
effectiveness, and usefulness of various peer review
activities. The outline of this section is as follows:
a. Integration of peer review tools into our routine work-
flow (eg, within treatment planning/management
systems);
b. Tools to streamline peer review of target doses/
prescriptions;
c. Tools to assist peer review of normal tissue exposures;
d. Tools to facilitate peer review of segmented anatomy;
and
e. Inter-center connectivity
4.3 Peer review in the context of evolving roles
The changing practice of radiation oncology is leading
to modification of traditional tasks ascribed to each team
member. Table 4 (available online only at www.
practicalradonc.org) illustrates some of these changes in
tasks and how this might have some implications for
peer review.4.4 Peer review in the context of education
See full text version available online only at www.
practicalradonc.org.
5.0 Discussion
See full text version available online only at www.
practicalradonc.org.
6.0 Summary of general recommendations
Peer review of important nontechnical decisions has
the potential to improve the quality of radiation therapy
patients receive. Thus, it should be embraced by leadership
and staff, and be considered part of the standard practice.
Leadership need to empower the staff to be involved in
peer review activities (eg, facilitate and support their in-
volvement) and provide the necessary infrastructure for ef-
ficient and effective peer review (eg, adequate space, image
display capabilities, access to electronic records, support
staff to help monitor and facilitate review, software tools).
Peer review should be conducted in the context of an
open and just culture, such that staff do not feel
threatened by the peer review process. For example,
people who are found to have made an honest mistake
should not face punitive measures. On the other hand,
people should be held accountable for failing to
participate in peer review activities.
Clear expectations for the “content” and the conduct of
peer review efforts (eg, the what, when, where, and how) are
necessary. Among the many targets relevant to improving
safety and quality with peer review methods, the most
obvious high-priority targets include the following.
(1) Physician. Physicians are indicated in 5 of the 7
prioritized items for peer review. In descending order,
they include the following: level 1, target definition;
level 2, decision to include radiation as part of
treatment, planning directive; level 3, general radiation
treatment approach, normal tissue image (Table 2).
(2) Dosimetrist. Level 2, technical plan quality (Table 2).
(3) Therapists. The first day of treatment delivery is con-
sidered level 1, high-priority peer review for radiation
therapists, especially in curative cases, IMRT, and
SBRT cases where there is no independent assess-
ment of the targeted volume. Other treatment days
are considered level 2, next highest priority (Table 2).
(4) Physicists. Level 1 for pretreatment setup verification
for complex cases (eg, SBRT). Level 2, technical plan
quality for treatments in general (Table 2).
The specific goals and targets of peer review should be
clearly specified, and the results of each peer review effort
ideally should be tracked. Creative ways to actively
monitor the clinical utility of peer review are needed to
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opportunities for improvement.
Users and vendors should collaborate to define and
create software and hardware tools that can help make peer
review more efficient and effective, and to keep track of
these peer review activities (eg, providing the ability for
annotation in the electronic medical record).
For small practices, where peer review is particularly
challenging, we encourage the creation of peer review
relationships among physicians from separate (perhaps
distant) practices.
The principles of peer review should be included in the
curriculum in educational programs. Students should be
included as participants in (or at least observers of) peer
review as it can be educational, promotes a culture of
respectful questioning (ie, students observe professionals
questioning each other), and reinforces the role and utility
of peer review as part of routine clinical practice.
Developing a successful comprehensive peer review
program requires the concerted activities of many people.
Example actions central to the peer review mission are
outlined in Table 5 (available only at www.practicalradonc.
org), for leadership, staff, and vendors, who can all help
facilitate improved safety and quality through more effec-
tive peer review.7.0 Conclusions
See full text version available online only at www.
practicalradonc.org.References
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